Quick Summary
- Hypertension is the largest single contributor to global cardiovascular death, and it is silent until it is not.
- Androgens raise blood pressure through sodium and water retention, effects on the renin-angiotensin system, and adverse changes in vascular stiffness and endothelial function.
- SPRINT demonstrated that intensive systolic control reduced cardiovascular events and death compared with a standard target in high-risk adults.
- Single office readings are the least reliable way to assess this. Home and ambulatory measurement is what guidelines increasingly rely on.
- It is cheap to measure, cheap to treat, and the treatments have decades of outcome data. Almost nothing else in this space offers that ratio.
If I could force one measurement on everyone in this world, it would not be a hormone panel or a peptide protocol. It would be a validated blood pressure cuff used properly at home, twice a day, for a week. Hypertension causes more cardiovascular death than any other modifiable factor, it produces no symptoms until the damage is done, and in a population that deliberately manipulates the systems controlling it, the prevalence is far higher than anyone acknowledges.
Why Androgens Raise Blood Pressure
Several mechanisms operate together, which is why the effect is consistent even when its size varies between individuals.
The most immediate is renal sodium and water handling. Androgens promote sodium retention, expanding plasma volume, and volume expansion raises pressure directly. Aromatisation to oestradiol adds further fluid retention in many users. This component is often rapid and is one reason blood pressure can climb within weeks of starting or increasing a dose.
Beyond volume, androgen exposure affects the renin-angiotensin-aldosterone system and appears to alter vascular tone through changes in nitric oxide bioavailability and endothelial function. Chronic exposure is associated with increased arterial stiffness. There is also a structural cardiac component: Baggish and colleagues documented left ventricular hypertrophy and impaired ventricular function in long-term illicit anabolic-androgenic steroid users, and a stiff, hypertrophied ventricle interacts badly with a high afterload.
Compounds vary. Those with strong mineralocorticoid-like effects or heavy aromatisation tend to produce more fluid retention. Oral 17-alpha-alkylated compounds are associated with worse effects overall, compounding a lipid profile that is already deteriorating. Stimulants used for training or fat loss add a sympathetic contribution. Nicotine, high sodium intake, poor sleep, untreated sleep apnoea, and non-steroidal anti-inflammatory drugs taken habitually for joint pain all stack on top.
What the Outcome Evidence Shows
The SPRINT trial is the reference point. It randomised high-risk adults without diabetes to a systolic target below 120 mmHg versus below 140 mmHg, and the intensive arm experienced fewer cardiovascular events and lower all-cause mortality, a result substantial enough that the trial was stopped early. The final report confirmed the benefit while also documenting more adverse events in the intensive group, including hypotension, syncope and acute kidney injury.
That trade-off is real and it is why targets are individualised rather than universal. The 2025 multi-society guideline on prevention, detection, evaluation and management of high blood pressure represents the current consensus synthesis of this evidence, and it is a physician’s job to apply it to a specific person. The general direction of travel over the past decade has been toward lower thresholds and lower targets, on the strength of trials like SPRINT.
What is not controversial is that untreated sustained hypertension damages arteries, kidneys, brain and heart progressively and silently, and that lowering it reduces stroke, myocardial infarction, heart failure and kidney disease. This is among the best-established causal relationships in medicine.
Measuring It Properly
Most of what people believe about their blood pressure is based on badly taken measurements. The technique matters as much as the device.
| Requirement | Why |
|---|---|
| Validated upper-arm cuff, correct size | Wrist devices and undersized cuffs on large arms both produce unreliable readings. A cuff too small for a muscular arm reads falsely high. This alone explains a large fraction of spurious results in lifters. |
| Seated, back supported, feet flat, arm at heart level | Unsupported back and dangling legs raise readings by several mmHg each. |
| Five minutes of quiet rest first, no talking during | Talking during measurement raises systolic pressure measurably. |
| No caffeine, nicotine, stimulants or training for 30 minutes | All acutely raise pressure. Post-workout readings tell you nothing about baseline. |
| Two or three readings a minute apart, averaged, twice daily for 7 days | Single readings are noisy. Guidelines rely on averaged home series or ambulatory monitoring, not one office measurement. |
| Record everything, including compounds and dose | The pattern over a cycle is the most informative data you will ever collect on your own physiology. |
That last row is where the real value sits. Someone who logs home blood pressure across a full cycle learns more about how a given compound affects them personally than any article can tell them. It also converts a vague anxiety into a decision: if pressure runs at 150/95 for eight weeks on a given protocol, that is not a grey area.
What Lowers It
The non-pharmacological levers are genuine but bounded. Reducing sodium intake, increasing dietary potassium, losing excess fat mass, moderating alcohol, adding regular aerobic work alongside resistance training, improving sleep, and treating sleep apnoea all produce measurable reductions, and together they can be substantial. Aerobic training in particular is undervalued by a population that considers cardio optional; it improves endothelial function and arterial compliance in ways that resistance training alone does not.
The largest and most reliable lever, for anyone whose hypertension is driven by what they are taking, is the dose and choice of compound. Reducing the dose, avoiding heavily aromatising or strongly fluid-retaining compounds, stopping oral agents, and shortening the duration of exposure address the cause rather than the symptom. That is a harder conversation than adding a pill, which is why it is usually avoided.
Antihypertensive medication is effective, inexpensive and supported by decades of outcome data. Which agent suits which patient is a clinical decision that depends on comorbidities, kidney function, ethnicity and other medications, and it is not something to self-select from a forum. Telmisartan in particular circulates in this community with a set of claims attached to it that go well beyond its evidence; it is a legitimate antihypertensive, prescribed for that purpose, not a performance supplement.
The Framing
Under the Tony Huge Laws of Biochemistry Physics, this is the clearest case of governors versus accelerators anywhere in the enhancement world, and the lesson runs opposite to the usual one. People spend years pushing accelerators and never once check whether the pressure in the system has exceeded what the pipework tolerates. Arteries are the pipework. There is no feedback mechanism that will tell you they are failing; the first symptom is frequently the event itself.
A cuff costs less than a month of almost any protocol discussed on this site. Measured properly and logged consistently, it is the single highest-yield piece of self-monitoring available, and it is the one most consistently skipped. Pair it with ApoB and, where appropriate, a calcium score, and you have a realistic picture of your cardiovascular trajectory rather than a hopeful one.
Where This Fits in the Bigger Picture
Monitoring is the part of enhancement that nobody posts about, and it is the part that decides how long you get to keep doing this. Testing gives you a feedback loop; without one you are guessing with your organs. Start with the Enhanced Athlete Protocol bloodwork guide, then work through the full protocol hub to see how testing, training, nutrition and recovery connect. If you are early in this, the beginners page is the right entry point.
See also the training pillar on integrating aerobic work, and the nutrition pillar on sodium, potassium and body composition.
Frequently Asked Questions
Does testosterone raise blood pressure?
Androgen use commonly raises blood pressure through several mechanisms, including sodium and water retention that expands plasma volume, effects on the renin-angiotensin system, increased arterial stiffness, and changes in endothelial function. The magnitude varies between individuals and between compounds, with heavily aromatising and orally active agents generally associated with larger effects, which is why individual measurement matters more than general expectation.
What is a normal blood pressure for a lifter?
The same thresholds apply to trained and untrained people; being muscular does not grant a higher acceptable range. What differs is measurement accuracy, because a cuff too small for a large arm reads falsely high. Use a correctly sized validated upper-arm cuff, and interpret averaged home readings taken over several days rather than a single office measurement.
How should I measure blood pressure at home?
Sit with your back supported and feet flat, rest quietly for five minutes, keep the cuffed arm supported at heart level, and do not talk during the reading. Avoid caffeine, nicotine, stimulants and exercise for at least thirty minutes beforehand. Take two or three readings a minute apart and average them, twice a day, for about a week to establish a reliable picture.
Can high blood pressure from steroids be reversed?
Blood pressure driven by fluid retention often improves after the contributing compound is reduced or stopped, sometimes within weeks. Changes that reflect longer-term structural adaptation, such as increased arterial stiffness or left ventricular hypertrophy, are slower to improve and may not fully resolve. This is a reason to monitor from the beginning rather than after years of unrecognised elevation.
Who needs blood pressure treatment?
That depends on the measured level, overall cardiovascular risk, and other conditions such as diabetes or kidney disease, and it is a decision for a physician working from averaged home or ambulatory readings. Trial evidence including SPRINT supports more intensive control in higher-risk adults, while also showing that intensive treatment carries its own adverse effects, so targets are individualised rather than universal.
References
- SPRINT Research Group. “A Randomized Trial of Intensive versus Standard Blood-Pressure Control.” N Engl J Med, 2015. doi:10.1056/NEJMoa1511939 (PMID 26551272)
- SPRINT Research Group. “Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.” N Engl J Med, 2021. doi:10.1056/NEJMoa1901281 (PMID 34010531)
- Jones DW, et al. “2025 AHA/ACC Multisociety Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults.” J Am Coll Cardiol, 2025. doi:10.1016/j.jacc.2025.05.007 (PMID 40815242)
- Baggish AL, et al. “Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.” Circulation, 2017. doi:10.1161/CIRCULATIONAHA.116.026945 (PMID 28533317)
- Peppard PE, et al. “Increased prevalence of sleep-disordered breathing in adults.” Am J Epidemiol, 2013. doi:10.1093/aje/kws342 (PMID 23589584)
- Lincoff AM, et al. “Cardiovascular Safety of Testosterone-Replacement Therapy.” N Engl J Med, 2023. doi:10.1056/NEJMoa2215025 (PMID 37326322)